MASSDEVICE ON CALL — China’s Food & Drug Administration released new review guidelines allowing foreign companies to apply for the agency’s new "fast track" review, a pathway previously only accepting domestic applicants.
A draft version of the regulation, issued last year, referred only to domestic companies but the final notice published this month allows foreign companies to make use of the pathway as well, JD Supra reported.
Devices granted fast-track access will get priority throughout the regulatory process and will be assigned a "dedicated liaison" to get the application through the review process, according to the report.
Applicants must demonstrate that they are "innovative," as defined by invention patents filed in China, improved safety and performance compared to existing devices and other parameters.
NASA analyzer heads to cancer ward
Scripps Translational Science Institute will begin testing a NASA-developed mobile chemical sensor that may be able to detect the chemical signature of lung cancer.
Read more
Cali groups working on transplantable retinas
California Stem Cell Inc. teamed up with the University of California, Irvine, to develop transplantable retinal tissue, funded by a $4.5 million grant from the California Institute of Regenerative Medicine.
Read more
Feds show increasing interest in telehealth
Federal regulators are showing increasing interest in telehealth and remote patient monitoring, with hopes that new technologies will bring cost-savings and extend care to under-served areas.
Read more
TransMedics gaining ground with "Lung in a Box"
Massachusetts-based TransMedics is making progress with its Organ Care System beginning with human lungs, keeping transplantable tissue "breathing" while en route to a transplant patient, rather than keeping the organ on ice.
Read more
